Related Experiment Video
Updated: Jul 10, 2026

Isolation and Physiological Analysis of Mouse Cardiomyocytes
Published on: September 7, 2014
[Status of the adrenal medulla in various forms of cardiomyopathy]
1A. L. Myasnikov Institute of Clinical Cardiology, RF Cardiology Research Center, Moscow.
Abstract:
Adrenal medulla was studied quantitatively by a histofluorescent method and by that of Wood in 20 persons who had died at the age 35-50 years. The autopsy material was obtained from 11 dead bodies (control group--accident death) and those who had dilated and alcoholic cardiomyopathy (DCMP and ACMP, respectively). Catecholamine luminescence intensity (CLI) was higher in ACMP compared to control. On the contrary, CLI was low in chromaffin adrenal tissue in DCMP. The histofluorescent results corresponded to those obtained by a light microscopy by Wood method. The differences in results concerning catecholamines obtained in ACMP and DCMP were probably due to the differences in their activities in patients when they were alive (low in DCMP and high in ACMP).
Related Concept Videos
Sympathetic Pathways: Collateral Ganglia and Adrenal Medulla
Collateral Ganglia
Sympathetic preganglionic axons reach the collateral ganglia along the route of splanchnic nerves. These nerves bypass the sympathetic trunk and communicate with sympathetic postganglionic neurons housed in the prevertebral ganglia. These ganglia supply the organs of the abdominopelvic cavity.
The greater splanchnic nerve, formed by the...
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy

